The in vitro component shown that both glucagon and Retatrutide right decreased ANGPTL3/8 secretion from hepatocytes, and this influence was blocked by a glucagon receptor (GCGR) antagonist. These results recommend that the GCGR agonism of Retatrutide contributes into the reduction in circulating